Stereotaxis (STXS) Preferred Stock Liabilities (2010 - 2026)
Stereotaxis (STXS) posted quarterly Preferred Stock Liabilities of $5.2 million for Q1 2026, down 1.06% year-over-year from $5.3 million in Q1 2025, and little changed quarter-over-quarter from $5.2 million in Q4 2025.
Stereotaxis (STXS) Preferred Stock Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Preferred Stock Liabilities for 12 consecutive years, with $5.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Stock Liabilities fell 1.06% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (down 1.06% YoY), while the FY2025 annual figure was $5.2 million, down 2.09% from the prior year.
- Preferred Stock Liabilities held at $5.2 million in Q1 2026 per STXS's latest filing, from $5.2 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $5.6 million in Q1 2022 and bottomed at $5.2 million in Q4 2025.
- Historically, Preferred Stock Liabilities has averaged $5.4 million across 5 years, with a median of $5.5 million in 2024.
- Annual changes were most pronounced in 2022 — Preferred Stock Liabilities grew 0.1% — and 2024, when it dropped 4.03%.
- Stereotaxis' Preferred Stock Liabilities stood at $5.6 million in 2022, then retreated by 0.11% to $5.6 million in 2023, then slipped by 4.03% to $5.4 million in 2024, then decreased by 2.09% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
- Business Quant data shows STXS's Preferred Stock Liabilities at $5.2 million in Q1 2026, $5.2 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.24 Mn |
| Sep 30, 2025 | 5.27 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | 5.58 Mn |
| Dec 31, 2022 | 5.58 Mn |
| Sep 30, 2022 | 5.58 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 5.58 Mn |